loadpatents
name:-0.0084459781646729
name:-0.0082588195800781
name:-0.0029139518737793
Weinberg; Andrew D. Patent Filings

Weinberg; Andrew D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Weinberg; Andrew D..The latest application filed is for "anti-cd55 antibodies and related compositions and methods".

Company Profile
2.6.7
  • Weinberg; Andrew D. - Portland OR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-CD55 Antibodies and Related Compositions and Methods
App 20220088193 - Montler; Ryan D. ;   et al.
2022-03-24
CD55-Binding Agent-Related Methods and Compositions
App 20210070858 - Montler; Ryan D. ;   et al.
2021-03-11
Utilization Of Cd39 And Cd103 For Identification Of Human Tumor Reactive T Cells For Treatment Of Cancer
App 20200149008 - Weinberg; Andrew D. ;   et al.
2020-05-14
Trimeric OX40-immunoglobulin fusion protein and methods of use
Grant 7,959,925 - Weinberg , et al. June 14, 2
2011-06-14
Trimeric Ox40-immunoglobulin Fusion Protein And Methods Of Use
App 20100136032 - Weinberg; Andrew D. ;   et al.
2010-06-03
Methods for using OX-40 ligand to enhance an antigen specific immune response
Grant 7,622,444 - Weinberg November 24, 2
2009-11-24
Methods for enhancing antigen-specific immune response using antibodies that bind OX-40
Grant 7,504,101 - Weinberg March 17, 2
2009-03-17
Compositions and methods for enhancing antigen-specific immune response
App 20070207159 - Weinberg; Andrew D.
2007-09-06
Trimeric OX40-immunoglobulin fusion protein and methods of use
App 20060280728 - Weinberg; Andrew D. ;   et al.
2006-12-14
T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions
Grant 6,566,082 - Weinberg , et al. May 20, 2
2003-05-20
Compositions and methods for enhancing antigen-specific immune response
App 20020054873 - Weinberg, Andrew D.
2002-05-09
Method for enhancing an antigen specific immune response with OX-40L
Grant 6,312,700 - Weinberg November 6, 2
2001-11-06
Treatment of CD4 T-cell mediated conditions
Grant 5,759,546 - Weinberg , et al. June 2, 1
1998-06-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed